发明授权
US07501440B2 Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use
有权
取代的苯甲酰脲基吡啶基哌啶和吡咯烷羧酸衍生物，其制备方法及其应用
- 专利标题： Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use
- 专利标题（中）： 取代的苯甲酰脲基吡啶基哌啶和吡咯烷羧酸衍生物，其制备方法及其应用
-
申请号： US10795863申请日： 2004-03-08
-
公开(公告)号： US07501440B2公开(公告)日： 2009-03-10
- 发明人: Karl Schoenafinger , Dieter Kadereit , Elisabeth Defossa , Andreas Herling , Thomas Klabunde
- 申请人： Karl Schoenafinger , Dieter Kadereit , Elisabeth Defossa , Andreas Herling , Thomas Klabunde
- 申请人地址： DE Frankfurt
- 专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人地址： DE Frankfurt
- 代理商 Barbara E. Kurys
- 优先权： DE10309929 20030307
- 主分类号： A61K31/4545
- IPC分类号： A61K31/4545 ; C07D401/04
摘要：
The invention relates to compounds of the formula I where the radicals are as defined, and their physiologically tolerated salts. The compounds are suitable, for example, as medicaments for preventing and treating type 2 diabetes.
公开/授权文献
信息查询
IPC分类:
